Chris Cabell Email & Phone Number
President, Head of Research and Development, Chief Medical Officer @ Inhibikase Therapeutics, Inc.
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Chris Cabell Location
- United States
Chris Cabell Work
- President, Head of Research and Development, Chief Medical Officer @ (February 2025 - Present)
- Founder @ HD CONSULTING SERVICES, LLC (December 2020 - Present)
- Member Board Of Directors @ (July 2020 - Present)
- Chief Executive Officer @ CorHepta Pharmaceuticals (August 2024 - February 2025)
- Chief Medical Officer @ (January 2023 - January 2024)
- Board Advisor @ (December 2019 - November 2023)
- Chief Medical Officer, Head of Clinical Development @ (February 2021 - January 2023)
- EVP, Head of R and D, Chief Medical Officer @ (June 2020 - November 2020)
- Chief Medical Officer @ (August 2019 - June 2020)
- Senior Vice President, Head of Clinical Development @ (October 2017 - June 2020)
- Senior Vice President, U.S. and Canada Head of Sales, Account Management, and Operations @ (January 2017 - October 2017)
- SVP , Global Head Therapeutic and Specialty Business Development @ (October 2014 - December 2016)
- SVP - Global Head, Therapeutic Delivery Unit @ (September 2010 - October 2014)
- SVP - Patient Recruitment and Site Management @ (January 2008 - September 2010)
- Chief Medical Officer @ (June 2008 - October 2008)
- Sr. Director - Medical and Scientific Services, Cardiovascular @ Quintiles (September 2007 - May 2008)
- Faculty @ (January 2002 - January 2007)
Chris Cabell Education
- Duke University School of Medicine
MD MHS
1990-1994
Chris Cabell Skills
- Regulatory Submissions
- New Drug Application (NDA)
- Drug Development
- Advisory Boards
- Scientific Communications
- Translational Science
- Clinical Trials
- Biotechnology Industry
- Investigational New Drug Application (IND)
- Clinical Trial Analysis
- Medical Research
- Board of Directors
- Clinical Research
- Biotechnology
- Project Management
- Sales
- Management
- Development
- Research
- Leadership
- Services
- Medicine
- Microsoft Office
- Business Development
Chris Cabell Summary
- Chris Cabell, based in United States, is currently a President, Head of Research and Development, Chief Medical Officer at Inhibikase Therapeutics, Inc.. Chris Cabell brings experience from previous roles at HD CONSULTING SERVICES, LLC, Pulmatrix Inc., CorHepta Pharmaceuticals and Zura Bio Limited. Chris Cabell holds a 1990 - 1994 MD MHS @ Duke University School of Medicine. With a robust skill set that includes Regulatory Submissions, New Drug Application (NDA), Drug Development, Advisory Boards, Scientific Communications and more. Chris Cabell has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Chris Cabell?
Find contact details for 700 million professionals.
Others Named Chris Cabell
Christopher Cabell
Founder and CEO
Boston, MA, US
Christopher Cabell
Assistant Driller
Springtown, TX, US
Christine Cabell
physician
Pennsylvania, United States
Top Inhibikase Therapeutics, Inc. Employees
Michael Scannell
Vice President, CMC Development
Holly Springs, NC, US
Alisha Lundholm
Senior Director, Corporate Controller
Boston, MA, US
Evette Brooks
Senior Director, Field Medical
Ladera Ranch, CA, US
Chad Orevillo
Executive Vice President, Head of Development Operations
San Diego, CA, US
Cisco Bee
Senior Director, CMC
Durham, NC, US
Jacqueline Pellecchia
Senior Clinical Trial Associate
Nashua, NH, US
Kristie Wagner
Vice President Finance
Framingham, MA, US
Mandi Warren
Senior Clinical Trial Manager
Vista, CA, US
Scotty Sengsavang
Head of Program Leadership
Cambridge, MA, US
Emaryn Mancino
Director Clinical Operations
Bordentown, NJ, US
Leona Blustein
Senior Director, Medical Affairs
Florida, United States
Jonathan L.
VP Medical Affairs
The Hague, ZH, NL
Ilksen Yoruk
Senior Director, RMA Europe
London, England, GB
Eshwari Kovoor
Director I Global Clinical Development
California, United States
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co